Make the ‘Digital Pharma’ vision a reality. Disrupt existing processes and establish new opportunities with predictive manufacturing, Big Data and advanced analytics, robotics and augmented reality—to name some technologies that can digitally transform you.
Companies that are able to adopt an agile strategy, digitize their core business, derive meaningful insights from data, scale up capabilities, create a differentiated ecosystem, and establish disruptive products/ services will be the ones to ace the future business landscape.
As your trusted partner and advisor in this journey, Columbus helps you evolve and transform digitally to become future ready.
The Life Sciences industry is unique in many ways, mainly because it “evolves” as companies go through the lifecycle from pre-clinical to market.
Each lifecycle phase has unique requirements, but often we come back to the same five key features that companies need to address with their business management and ERP solutions.
Congratulations! You’ve made it past the most significant product lifecycle barrier—FDA approval. Now, it’s time for the manufacturing, sales and fulfillment that come with commercialization. This means new system challenges need to be addressed. Read the fact sheet to know more.
As you prepare your company to go commercial, there are many things you need to consider in terms of your solution. These considerations will depend not only on your business model but also the proportion of in-house and outsourced business processes.
While pharmaceutical companies generally purchase a software solution specifically designed to track their aggregate spending to HCPs, the ERP solution generates much of the information, which becomes the input for the aggregate spend system. How the spending should be tracked?